Total:€ 348,00
Cardiometabolic & Endothelial Insight
€ 329,00
An integrated blood and urine assessment combining core cardiometabolic markers with ADMA and oxidative DNA and lipid-damage indicators. The panel connects glucose regulation, insulin, lipids, inflammation and organ function with endothelial nitric-oxide signalling and oxidative burden.
Beschrijving
WHL Integrated Diagnostic Panel
Cardiometabolic & Endothelial Insight
VitaGlow 360 Basic + ADMA + Oxidative Stress Profile
€329
€378
Save €49
€378
Save €49
Why combine these tests?
Conventional metabolic markers describe important risk factors, but they do not fully show how the vascular lining or cellular structures may be affected. This panel adds ADMA—a marker related to nitric-oxide availability and endothelial regulation—and targeted oxidative-damage markers to a broad metabolic, inflammatory and organ-function baseline. The result is a more connected view of factors relevant to long-term vascular and metabolic health.
Test 1 · Blood
VitaGlow 360 Basic
Provides the cardiometabolic foundation: blood count, liver and kidney markers, fasting glucose, HbA1c, insulin, lipid profile, ferritin, vitamin D, vitamin B12, folate and hs-CRP.
Test 2 · Blood
ADMA
Measures asymmetric dimethylarginine, an endogenous inhibitor of nitric-oxide synthase. Elevated ADMA may be associated with reduced nitric-oxide availability and impaired endothelial regulation.
Test 3 · Blood + Urine
Oxidative Stress Profile
Assesses 8-OHdG and lipid peroxides to provide targeted information about oxidative damage involving DNA and lipids or cell membranes.
What the combined panel can help clarify
Glucose and insulin regulation: fasting glucose, HbA1c and insulin provide complementary short-, medium- and longer-term metabolic context.
Lipid and inflammatory context: the lipid profile and hs-CRP help place vascular findings within established cardiometabolic risk domains.
Endothelial nitric-oxide signalling: ADMA adds information about a pathway involved in vascular tone, blood-flow regulation and endothelial function.
Oxidative damage: 8-OHdG and lipid peroxides assess biochemical damage affecting DNA and lipid structures.
Interpretive context for ADMA: kidney-function and metabolic markers included in VitaGlow Basic are relevant when considering an ADMA result.
Key measurements included
Metabolic
Fasting glucose, HbA1c, insulin and lipid profile
Fasting glucose, HbA1c, insulin and lipid profile
Inflammation & nutrients
hs-CRP, ferritin, vitamin D, vitamin B12 and folate
hs-CRP, ferritin, vitamin D, vitamin B12 and folate
Organ function
CBC, ALT, AST, ALP, GGT, BUN and creatinine
CBC, ALT, AST, ALP, GGT, BUN and creatinine
Vascular & oxidative
ADMA, 8-OHdG and lipid peroxides
ADMA, 8-OHdG and lipid peroxides
Who may consider this panel?
- Insulin resistance or metabolic-syndrome concerns
- Hypertension or other vascular risk factors
- Unfavourable lipid or glucose results
- Chronic low-grade inflammatory burden
- Family history of cardiometabolic disease
- Preventive or healthy-ageing assessment
Sample requirements
Blood: blood collection is required for VitaGlow Basic, ADMA and the blood component of the Oxidative Stress Profile.
Urine: a urine sample is required for the urinary component of the Oxidative Stress Profile.
Collection materials: WHL supplies or confirms the required blood tubes, urine container, handling and return instructions.
Before collection
✓ Fasting is normally required because the panel includes fasting glucose and insulin; follow the exact WHL instructions.
✓ Water is generally permitted during fasting unless the collection instructions state otherwise.
✓ Record medication and supplements that may influence metabolic, inflammatory or oxidative-stress markers.
✓ Follow the kit instructions for urine timing, sample storage and transport.
Important: Do not stop prescribed medication for testing unless the prescribing healthcare professional advises you to do so.
Clinical note: This panel supports cardiometabolic, endothelial and oxidative-stress assessment. It does not diagnose cardiovascular disease and does not replace blood-pressure measurement, clinical examination, ECG, imaging or urgent medical assessment when symptoms are present. Results should be interpreted together with medical history, renal function, medication, lifestyle and established cardiovascular risk factors.
